The effect of parenteral vitamin B12 on the growth rate of dairy calves over the summer and autumn on seven farms from the Central Plateau, New Zealand.

AIMS: To investigate the effect of parenteral vitamin B12 supplementation on the growth rate of dairy heifer calves over the summer and autumn on seven farms from the Central Plateau of New Zealand, an area historically associated with low cobalt levels in grazing pasture. METHODS: This was a controlled clinical trial conducted on a convenience sample of seven farms with young female calves randomly assigned to three vitamin B12 treatment groups and followed through a grazing season. Two treatment groups received either monthly SC injections of a short-acting (SA) B12 formulation or 3-monthly injections of a long-acting (LA) B12 formulation and the third group received no treatment (NT). No additional parenteral vitamin B12 was given; however, all calves received additional cobalt (0.04-0.4 mg Co/kg liveweight) in the mineralised anthelmintic drenches given orally every month. Liveweight was recorded in December/January and at the end of the trial in May/June/July depending on farm. Pasture cobalt concentrations (mg/kg DM) were measured every month using 500-g herbage samples from 100-m transects in the area about to be grazed by the trial groups. RESULTS: There was evidence for a difference in growth rate between groups with mean final weight of 228 (95% CI = 212-243) kg for the LA groups, 224 (95% CI = 209-239) kg for the SA groups and 226 (95% CI = 211-241) kg for the NT groups respectively, (global p-value = 0.014). Calves given SA vitamin B12 were 3.77 (95% CI = 0.71-6.82) kg lighter than calves given LA vitamin B12 (p = 0.011). There was no evidence for a change in pasture cobalt concentrations (p = 0.32). CONCLUSIONS AND CLINICAL RELEVANCE: The results of this trial raise the question as to whether the routine use of vitamin B12 supplementation in young cattle from areas traditionally thought to be cobalt deficient is necessary, and further raise the possibility that vitamin B12 supplementation by repeated injection of SA products may negatively impact growth rates.

The effect of pre-calving injection of trace mineral supplements on periparturient disease incidence in pasture based dairy cows.

Trace minerals, have a role in immune function and a trace mineral supplement (TMS) can improve animal health in dairy herds. This prospective randomised clinical study assessed whether subcutaneous injection of 5.5 mL of TMS (40 mg zinc, 10 mg manganese, 5 mg selenium, 15 mg copper per mL), 14-28 days before planned start of calving (PSC) reduced clinical mastitis (CM), subclinical mastitis (SCM) and purulent vaginal discharge (PVD). From four farms, half of 1700 cows stratified on somatic cell count, age and breed were randomly allocated to treatment or no treatment. Occurrence of CM from - 7 to PSC + 100 days, SCM at PSC + 60 days and PVD at PSC + 24 days was analysed using survival analysis and Bayesian generalised mixed multivariable models. From -7 to PSC +30 days, TMS reduced the adjusted hazard ratio (HR) for CM at quarter and cow level (P < 0.001), with no evidence for an effect beyond 30 days. The adjusted OR (and 95% highest density interval, HDI) for the effect of TMS on CM from -7 to PSC +30 days was 0.40 (95% HDI, 0.26-0.63) at quarter level, 0.51 (95% HDI, 0.38-0.69) at cow level and for SCM, 0.72 (95% HDI, 0.54-0.95). The difference in CM incidence from TMS at the cow level was -2.0% (95% HDI, -3.4 to -1.1%) and -1.2% (95% HDI, -3.2 to - 0.6%) at quarter level. No clear effect was identified of TMS on cumulative incidence of PVD.

The transfer of passive immunity in calves born at pasture.

Calf and dam separation is an area of growing public interest, and timely separation is also a practical challenge for pastoral farmers to achieve for all calves. Very few studies have investigated the success of leaving calves with their dams in pastoral conditions, so this observational study assessed serum total protein (STP) in calves born at pasture and left to suckle from their dams for up to 24 h. It also investigated failure of transfer of passive immunity (FPT) once calves had been provided colostrum from the farmer and some factors that may contribute to the risk of FPT. Over 2 years, 8 farms (4 in the North Island, 4 in South Island of New Zealand) were involved in an observational study where cows and calves were observed for 24 h a day for 2 wk per farm. Observers recorded the time from birth to first suckling, number of suckling events, time of calf removal from the dam, and ambient temperature. Calves were blood sampled on arrival at housing, before receiving colostrum from the farmer (d 1), and again 2 d later (d 3) to test for STP concentration. On d 1, 689 calves had blood samples collected, at a median of 11.5 (interquartile range 5.6 to 19.2) hours postbirth. Of these, 283 calves [41.1%; 95% confidence interval (CI) 37.4 to 44.9%] had STP >52 g/L (proportion by farm ranged from 10 to 78%). On d 3, 680 blood samples were collected, of which 16.0% (95% CI 13.5 to 19.0) had FPT (STP ≤52 g/L) with proportion by farm ranging from 2.5 to 31.6%. The FPT risk at d 3 in calves that did not suckle before housing was 2.91 (95% CI 2.04 to 4.13) times the risk in calves that suckled. For every hour longer postbirth that it took for a calf to have its first suckling event, odds of FPT at d 3 increased by 1.21 (95% CI 1.08 to 1.36) times, and compared with calves that only suckled once, calves that suckled 2, 3-5, or >5 times had 0.42 (95% CI 0.15 to 0.99), 0.35 (95% CI 0.15 to 0.76), and 0.10 (95% CI 0.005 to 0.47) times the odds of FPT, respectively. For every 1-percentage-point increase in the Brix % of the colostrum, the odds of FPT decreased by 33% (95% CI 24- to 42). Calves that suckled in the paddock and were fed colostrum with ≥22% Brix had the highest STP, and lowest odds of FPT, of any suckling/Brix % combination. There was a trend for STP to be greater in calves that suckled in the paddock and fed <22% Brix compared with calves that did not suckle in the paddock and fed ≥22% Brix. However, the calves in the former group also tended to have a greater risk of FPT at d 3, and a greater STP variability. There were very large between-farm variabilities for rates of suckling, colostrum feeding, and FPT risk that urgently require further investigation for calves born at pasture.

Quantification of zinc concentrations in serum, milk and faeces of dairy cattle as a measure of effective zinc supplementation for management of facial eczema.

AIMS: To investigate the relationship between Zn concentrations in serum and those in milk or faeces, and to assess the ability of the Zn concentrations in milk, serum and faeces to predict intake of ZnO in dairy cattle. METHOD: Seventy cows from one commercial farm in the Waikato region of New Zealand received one of seven dose rates (0, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 g/100 kg bodyweight (BW)) of ZnO given by oral drench, every morning, for 7 consecutive days. Every afternoon, milk and blood samples were collected from all cows. Free-catch faecal samples were collected during the afternoon milking on 3 days throughout the trial.Linear mixed models were used to assess the relationship between the concentration of Zn in serum and that in milk, and in faeces, respectively, and the relationship between dose rate of ZnO and concentrations of Zn in serum, faeces and milk, respectively. Receiver operating characteristic curve analysis was used to determine the ability of the Zn concentration in serum, milk and faeces to predict that a cow had been treated with a dose of ZnO ≥2.5 g/100 kg, the industry-recommended dose rate needed to protect against facial eczema. RESULTS: A 1-µmol/L increase in Zn concentration in milk was associated with a 0.14 (95% CI = 0.11-0.17) µmol/L increase in Zn concentration in serum. Zn concentration in faeces was scaled by its SD; a 1 SD increase was associated with a 1.83 (95% CI = 0.54-3.12) µmol/L increase in zinc concentration in serum. Zn concentrations in serum and faeces increased with increasing dose rates of ZnO. No differences in Zn concentrations in milk were noted between animals dosed with 1.5-3.5 g ZnO/100 kg BW, inclusive. At the optimal threshold of Zn concentration in serum to predict protective ZnO intake (22 µmol/L), the sensitivity was 0.76 (95% CI = 0.69-0.82) and specificity 0.85 (95% CI = 0.80-0.89). For the concentration of Zn in faeces, the optimal threshold was 17.36 mmol/kg, with a corresponding sensitivity of 0.84 (95% CI = 0.84-0.85) and specificity of 0.85 (95% CI = 0.73-0.94). At the optimal threshold for the Zn concentration in milk (76.6 µmol/L), the sensitivity was lower than the other two sample types at 0.59 (95% CI = 0.52-0.67), but with a similar specificity of 0.84 (95% CI = 0.79-0.88). CONCLUSIONS AND CLINICAL RELEVANCE: The concentration of Zn in milk shows promise as an initial screening test to identify dairy farms that do not provide adequate zinc to provide protection against FE.

Changes in the metabolic profiles of dairy cows before and after calving that were mainly fed fodder beet (Beta vulgaris vulgaris L.) during the dry period.

Case history: Two commercial pasture-based farms within the North Canterbury district of New Zealand were feeding fodder beet (Beta vulgaris vulgaris L.) as a large proportion of the diet to cows during the dry period. On each farm 25 multiparous cows were blood sampled up to six times from 28 days before, to 21 days after calving (Day 0). Plasma samples were analysed for concentrations of ß-hydroxybutyrate (BHBA), non-esterified fatty acid (NEFA), Ca, Mg and P, and aspartate aminotransferase (AST) activity. The first sampling visit was performed when cows were being fed their maximum intake of fodder beet. Clinical findings: The mean body condition score (BCS) of cows on Farm 1 was 5.4 (95% CI = 5.3-5.6) and on Farm 2, 5.4 (95% CI = 5.3-5.6) at first sampling. Mean concentrations of BHBA increased between Days -15 and Day -8 then decreased postpartum on Day 2 before increasing again on Day 21. On Farm 2, concentrations remained low (<1.2 mmol/L) on all days of sampling. Mean concentrations of NEFA in plasma remained low during the periparturient period on Farm 1, then increased on Day 2. On Farm 2, concentrations were elevated above 0.3 mmol/L between Days -28 and -17 then decreased on Day -10, before increasing on Day 2. Mean concentrations of Ca, Mg and P were higher than threshold values on both farms prepartum. However on Day 2, there were 8/23 (35%) cows on Farm 1 and 6/23 (26%) cows on Farm 2 with concentrations of Ca in plasma <2.0 mmol/L, and 10/23 (44%) cows on Farm 1 and 8/23 (35%) cows on Farm 2 with concentrations of P in plasma <1.3 mmol/L. Mean AST activities remained relatively constant and below 130 IU/L on both farms at all sampling times. Clinical relevance: On both farms, post-partum hypocalcaemia and hypophosphataemia were common after calving despite differing fodder beet feeding and mineral supplementation regimes. There was more variation in energy status, especially prior to calving. More research is required on factors affecting mineral and energy status in dry cows fed fodder beet.

Selenium requirements in grazing dairy cows: a review.

In New Zealand, the recommended intake of Se for dairy cattle (0.03 mg/kg dry matter (DM)) is lower than in the United Kingdom and Australia (0.1 and 0.04 mg/kg DM, respectively), and much lower than in the United States of America (0.3 mg/kg DM). Advisors in New Zealand often suggest that New Zealand intake recommendations are far too low and that recommendations from the United States of America should be used. This has created confusion as farmers are given very different advice depending on which recommendations their advisor uses. In this review, we assess whether the published evidence supports the existing dietary requirements and associated Se status thresholds, or if change is required. We focus particularly on the evidence-base in cattle fed a primarily pasture-based diet, as it is critical that dietary recommendations are derived from data created using cows fed similar diets. Accordingly, we also consider whether the increased use of fodder crops, especially during the dry period, is likely to have altered the Se requirements of dairy cows in New Zealand. We report that the science behind the dietary requirements for Se is robust, being supported by factorial models validated using New Zealand data, and on-farm experimental studies. Published nutritional data suggest that the increased use of fodder crops is unlikely to have altered the dietary balance of pro- and antioxidant factors in New Zealand dairy cows in a way that would meaningfully affect Se requirements. However, the lack of specific data on the vitamin E and fatty acid content of the crops being fed in New Zealand means that more information is needed to confirm this conclusion. In general, the existing New Zealand recommendations for Se-status thresholds are supported, although studies are still lacking to properly characterise the upper threshold of the marginal range. Nevertheless many studies in New Zealand, of herds with marginal or low adequate Se status (using New Zealand recommendations), have failed to show an effect of Se supplementation on milk production, intramammary infection or reproductive performance, so it is highly unlikely that the upper threshold of the range is much higher than the current recommendation. Proponents of the hypothesis that Se intakes in New Zealand dairy cattle should be increased by at least 10 times the current recommendations are therefore not using the evidence base correctly.

A review of diagnostic tests for diagnosing failure of transfer of passive immunity in dairy calves in New Zealand.

The aim of this review is to critically assess the test characteristics and practicality of published data on direct and indirect tests for diagnosing failure of transfer of passive immunity (FPT) in dairy calves in New Zealand, to provide recommendations for veterinary practitioners, and to examine the recommended sample size for assessing herd-level prevalence of FPT and the confidence in the results obtained. The definition of FPT is based on measurement of concentrations of IgG in serum of neonatal calves after colostrum intake. The gold standard method for measurement of concentrations of IgG is radial immunodiffusion. However its cost, requirements for laboratory equipment, and the time taken to obtain results have meant that alternative tests have been developed. The turbidimetric immunoassay and ELISA also directly measure concentrations of IgG. Indirect tests include measurement of concentrations of total proteins (TP) in the laboratory or using a refractometer, γ-glutamyl transferase (GGT) activity, and the zinc sulfate turbidity (ZST) test. Of the indirect tests, measurement of concentrations of TP in the laboratory or using a refractometer combine high specificity and sensitivity with a consistent association with concentrations of IgG in calves between 1-7 days of age. Using a refractometer is less accurate than direct measurement in a laboratory, but is still a suitable test if low cost and speed are important. Although GGT activity is strongly associated with concentrations of IgG in serum, the relationship varies with time after birth. Therefore the target thresholds change with time, increasing error compared to the measurement of concentrations of TP in serum. Similarly, factors other than total concentrations of IgG have a significant effect on the association with ZST test, complicating interpretation. Thus, when direct measurement of concentrations of IgG is not feasible, the recommendation is that concentrations of TP in serum should be used as the diagnostic test for diagnosis of FPT, providing calves are not dehydrated. Using a sample size of 12 calves is suitable for estimating whether the herd-level prevalence of FPT is <20% or >20%, if there are no calves or >5 calves diagnosed with FPT, respectively, but is limited in diagnostic confidence when 1-4 calves test positive. Diagnostic interpretation can be significantly improved if tests of FPT are used alongside information on the likely risk of FPT on the tested farm.

Effects of a topically applied anaesthetic on the behaviour, pain sensitivity and weight gain of dairy calves following thermocautery disbudding with a local anaesthetic.

Aims: To compare the effect of a topically applied anaesthetic to no pain relief or meloxicam on the behavioural responses, pain sensitivity and weight gain of calves following disbudding with or without sedation. Methods: A total of 364, 2-6 week-old calves from three commercial farms were systematically allocated to one of six treatment groups. All calves received a cornual nerve block prior to disbudding, with half restrained in a crate and half sedated with xylazine. Within these groups one third received no further treatment (control), one third were treated with meloxicam >10 minutes prior to disbudding and one third received a topical anaesthetic applied to the horn bud wounds following disbudding. The frequency of ear flicks, head shakes, head scratches and pain sensitivity of the wound were recorded on up to eight occasions over 24 hours after disbudding. Calves were weighed before, and 7 and 28 days after, disbudding to determine average daily weight gain (ADG). Results: Compared to calves in the crate-control group, all other groups had reduced ear flicks at all times following disbudding (p < 0.01). Treatment with meloxicam and topical anaesthesia in addition to sedation reduced head scratches compared to calves in the crate-control group (p ≤ 0.013). At 22 hours after disbudding head shakes were reduced in sedated calves treated with topical anaesthetic compared to calves in the crate-control group (p < 0.001). Pain sensitivity was lower in all sedated calves than unsedated calves (p < 0.001). The ADG between Days 0-7 was 0.14 (95% CI = 0.015-0.274) kg/day greater in sedated calves treated with meloxicam than calves in the crate-control group (p = 0.03), and the ADG between Days 0-28 tended to be 0.06 (95% CI=-0.01-0.13) kg/day greater in sedated calves treated with topical anaesthetic than calves in the crate-control group (p = 0.09). Conclusion and clinical relevance: Sedation of calves for disbudding reduced the pain experienced in the following 24 hours. There was a benefit to providing calves with topical anaesthetic following disbudding on behavioural responses and pain sensitivity, which was similar to that of treating calves with meloxicam.

Effect of sodium molybdate supplementation on high concentrations of Cu in liver of yearling bulls.

AIM: To determine the impact of sodium molybdate treatment, given weekly, on concentrations of Cu in liver, activity of liver enzymes, and weight gain over 4 weeks, in yearling bulls with elevated concentrations of Cu in liver. METHODS: The study was carried on two commercial grazing farms in the Otago region of New Zealand in yearling Friesian bulls (n=150 on Farm A and n=49 on Farm B) with mean concentration of Cu in liver >3,000 µmol/kg fresh weight. On Day 0, all animals were weighed and half were systematically allocated to treatment with sodium molybdate (3 mg/kg liveweight on Farm A and 7 mg/kg liveweight on Farm B); the remainder received no treatment (Control). Sodium molybdate was given as a drench weekly for 4 weeks and all animals were weighed again on Day 28. Ten animals on each farm (five from each treatment group) were systematically selected for blood sampling and liver biopsies on Days 0 and 28. Samples were analysed for concentrations of Cu in plasma, vitamin B12 in serum, activities of γ-glutamyl transferase, aspartate aminotransferase and glutamate dehydrogenase in serum, and concentrations of Cu and vitamin B12 in liver. Separate multivariable linear models were used to compare the change in outcome variables between Days 0 and 28 between bulls that had been drenched with sodium molybdate or not. RESULTS: On Farm A, mean concentrations of Cu in liver on Day 28, as a percentage of concentrations on Day 0, for the control group was 55 (95% CI=40-73)% and for the treatment group was 73 (95% CI=43-111)%. On Farm B, the equivalent mean for the control group was 75 (95% CI=42-131)% and for the treatment group was 85 (95% CI=38-134)%. The multivariable linear models indicated that the changes in concentrations of Cu in liver, activities of liver enzymes and weight gain between Days 0 and 28 did not differ between the bulls treated or not with sodium molybdate (p>0.18). CONCLUSIONS AND CLINICAL RELEVANCE: Treatment with sodium molybdate in one bolus at weekly intervals for 4 weeks did not affect concentrations of Cu in liver, activity of liver enzymes or weight gain in animals with high concentrations of Cu liver on two farms.

Calf and colostrum management practices on New Zealand dairy farms and their associations with concentrations of total protein in calf serum.

AIMS: To gather information on management practices and farmer attitudes to management of cows and calves during the immediate post-partum period on dairy farms in New Zealand, and to assess these practices for associations with concentrations of total protein (TP) in serum of calves 1-8 days-old. METHOD: Between July and September 2015 blood samples were collected from calves aged between 24 hours and 7 days, from dairy farms (n=105) in nine areas in New Zealand, on three occasions throughout the calving period. Concentrations of TP were determined in all serum samples. At each visit technicians collected 1 L of the pooled colostrum that was intended for feeding to newborn calves that day. These samples were assessed for Brix, coliform and total bacterial counts. After the last sampling visit, the calf rearer or farm manager were asked to complete a questionnaire describing calf and colostrum management practices on the farm. Potential farm-level variables associated with concentrations of TP in serum of sampled calves were identified using univariable and multivariable linear mixed models. RESULTS: Mean concentration of TP in serum of calves across all farms was 59.8 (95% CI=59.4-60.2) g/L, and was associated with region and herd size in the final multivariable model. Concentrations of TP were lower in calves from farms in Otago (56.2 (95% CI=53.4-58.9) g/L) and Southland (56.9 (95% CI=54.1-59.7) g/L) compared to calves on farms in the Far North (62.6 (95% CI=59.8-65.3) g/L), and were lower in calves from farms with a herd size >600 (58.3 (95% CI=56.7-59.8) g/L) than ≤600 (61.3 (95% CI=60.1-62.5) g/L) cows. After accounting for fixed effects, farm accounted for only 8.4% of the unexplained variation. There was no association between any of the measures of colostrum quality and concentrations of TP in serum (p>0.2). CONCLUSION AND CLINICAL RELEVANCE: Very few herd-level variables were associated with concentrations of TP in serum. Risk factors that have been shown to be of importance in previous studies outside New Zealand were not identified as important in the current study. It is possible that, in the situation where calves are kept at pasture with their dams for prolonged periods, variables which influence how well a cow can feed its calf in the first 12-24 hours have a larger influence on concentrations of TP in serum than the collection and management of calves once they reach the rearing shed.

Prevalence and calf-level risk factors for failure of passive transfer in dairy calves in New Zealand.

AIM To determine the prevalence of failure of passive transfer (FPT) in dairy calves in New Zealand and to assess a range of potential calf-level risk factors for their association with FPT. METHOD Between July and September 2015, 107 dairy farms in nine regions across New Zealand were visited on three occasions: before 20% of cows had calved, when ∼50% of cows had calved, and when the last 10-20% of cows were calving. Farms were randomly selected from the client list of participating veterinary practices. On each farm, blood samples were collected from 10-20 calves between 24 hours and 8 days old and concentrations of total protein (TP) in serum determined. Calf identification, date of birth, dam's age and breed, details of colostrum feeding and the farmer's health assessment of the calf on arrival at the calf rearing facility were recorded. Concentrations of TP in serum ≤52 g/L were used to define FPT. RESULTS Of 3,819 calves sampled, 1,263 (33 (95% CI=31.6-34.6)%) were diagnosed with FPT, and the prevalence within farms ranged from 5-83%. Calf-level risk factors that were associated with increased odds of FPT were increasing age of dam (OR=1.12; 95% CI=1.08-1.16), calves recorded as unhealthy compared to healthy upon arrival at the calf rearing facility (OR=2.59; 95% CI=1.60-4.19), calves sampled on farms in Otago (OR=2.85; 95% CI=1.42-5.74) and Southland (OR 2.31; 95% CI=1.15-4.67) compared to the Far North, and calves sampled in the middle compared to the early calving period (OR=1.24; 95% CI=1.03-1.51). CONCLUSION On the farms visited FPT was diagnosed in one third of dairy calves. Calf-level risk factors for FPT included age of dam, health status of calf, region, and time of the calving period. Further investigations are required to establish why these are associated with increased odds of FPT. CLINICAL RELEVANCE These results provide a baseline for benchmarking, which, alongside the reported calf-level risk factors, can be used by veterinarians to improve colostrum management.

Facial eczema management protocols used on dairy farms in the North Island of New Zealand and associated concentrations of zinc in serum.

AIMS: To describe and evaluate the current practices used to manage and prevent facial eczema (FE) in North Island dairy herds, and determine the within-herd prevalence of cows with elevated activities of gamma glutamyl transferase (GGT), and with concentrations of Zn in serum <18 µmol/L. METHODS: Between January and May 2014, 105 herd managers from throughout the North Island of New Zealand were invited to participate in the study when regional spore counts for Pithomyces chartarum started to rise towards 30,000 spores/g pasture. Managers selected 10 representative cattle that were weighed and blood-sampled by the herd veterinarian. Blood samples were analysed for concentrations of Zn in serum and GGT activity. Pasture samples were also collected and submitted for spore count estimation. Finally a survey of farm management practices relating to prevention of FE was completed by the herd manager. A mixed-effects logistic regression model was used to determine associations between herd-level and cow-level explanatory variables and the probability of a cow having a concentration of Zn in serum <18 µmol/L. RESULTS: Of the 1,071 cows tested, 79 (7.3 (95% CI=5.8-9.0)%) had GGT activity in serum >300 IU/L, and 35/106 (33 (95% CI=24.2-42.8)%) herds had ≥1 of the 10 cows sampled with GGT activity >300 IU/L. Of the 911 cows that were being treated with Zn, concentrations of Zn were between 18-35 µmol/L in 398 (43.6 (95% CI=40.4-46.9)%) cows, were >35 µmol/L in 32 (3.5 (95% CI=2.4-4.1)%) cows, and <18 µmol/L in 479 (52.6 (95% CI=49.3-55.9)%) cows. After adjusting for the confounding effect of region, the odds of a cow having concentrations of Zn in serum <18 µmol/L were 5.5 (95% CI=1.1-29) times greater for cows supplemented with zinc in water compared with those supplemented by drenching. Of the 105 herd managers, 103 (98%) stated that they had access to regional spore count data, but only 35/105 (33%) reported that they measured spore counts on their own farm. Overall, 98/105 (93%) managers reported that they had some form of FE management programme in place. Fungicides were used on their own or in combination with zinc treatments in 10 herds, ZnSO4 in water troughs was used in 68 herds, oral drenching with ZnO in nine herds, and ZnO supplied in-feed in 26 herds. Estimated daily dose rates of zinc were less than that required to treat a 400 kg cow on 42/68 farms that administered ZnSO4 in the water or ZnO as a drench. CONCLUSION AND CLINICAL RELEVANCE: This study has shown that FE management on dairy farms in the North Island of New Zealand could be substantially improved. It is likely that improved FE management would occur if herd managers were provided with more feedback on the success (or otherwise) of their FE management programmes.

The effect of different combinations of local anaesthesia, sedative and non-steroidal anti-inflammatory drugs on daily growth rates of dairy calves after disbudding.

AIM: To assess the effect of sedation and local anaesthesia (LA) at disbudding, and the addition of meloxicam or ketoprofen treatment, on weight gain in dairy calves following disbudding. METHODS: Friesian-Jersey cross calves, from four dairy farms, were enrolled when 3-6 weeks old. All calves (n=271) were disbudded by veterinary personnel and randomly assigned to six groups: 136 were disbudded without sedation or LA, of which 31 received 20 mg meloxicam S/C and 75 received 150 mg ketoprofen I/M. A further 135 were disbudded with sedation (0.25 mg/kg xylazine I/M) and LA, of which 30 also received meloxicam and 75 received ketoprofen. Calves were weighed 3 days before, and 15 and 30 days after, disbudding (Day 0). Daily weight gain was analysed using mixed models and ANOVA. RESULTS: Complete results were obtained from 263 calves. From Day -3 to Day 15, the growth rate of calves disbudded without pain relief (0.53 (95% CI=0.47-0.60) kg/day) was less that of calves disbudded with some form of pain relief (0.65 (95% CI=0.62-0.68) kg/d; p=0.004). There was no difference between the effect of meloxicam or ketoprofen (p=1.00). An interaction between use of sedation and LA and additional non-steroidal anti-inflammatory drugs (NSAID) meant that NSAID treatment did not increase growth rates in calves disbudded with sedation and LA but did increase growth rates for calves disbudded without pain relief (p<0.05). From Day 16 to Day 30 there was no effect of NSAID treatment on growth rate, but calves receiving LA and sedation grew faster (0.74 (95% CI=0.69-0.80) kg/day) than calves disbudded without LA and sedation (0.66 (95% CI=0.61-0.71) kg/day; p=0.018). From Day -3 to Day 30, calves disbudded with sedation and LA grew faster (0.71 (95%CI=0.64-0.77) kg/day) than calves disbudded without sedation and LA (0.60 (95% CI=0.55-0.65) kg/day; p=0.011). However, addition of NSAID to sedation and LA made no further difference to growth rates (p=0.69). CONCLUSIONS: Dairy calves disbudded with no pain relief had slower growth rates than calves receiving pain relief. From Day 15 to 30 calves given no pain relief, or NSAID alone, grew more slowly than those receiving sedation and LA at disbudding. The addition of NSAID treatment to sedation and LA did not further increase growth rates. CLINICAL RELEVANCE: This study adds to the evidence that pain management when disbudding is beneficial for calf productivity as well as calf welfare.

Effect of analgesia and anti-inflammatory treatment on weight gain and milk intake of dairy calves after disbudding.

AIM: To assess the effect of analgesia at disbudding on weight gain and milk intake of dairy calves. METHODS: Four disbudding protocols were used on 3- to 6-week-old Friesian-Jersey calves. Farm staff disbudded 101 calves without sedation or local analgesia, of which 51 received 20 mg meloxicam S/C. Veterinary staff disbudded 101 calves with sedation and local analgesia, of which 51 also received 20 mg meloxicam S/C. Calves were weighed before disbudding, 15 and 30 days later, and individual milk consumption was recorded for 11 days. Daily weight gain and milk consumption were analysed using mixed models and ANOVA. RESULTS: From disbudding (Day 0) to Day 15 farmer-disbudded calves receiving meloxicam grew faster (0.65 kg/day) than calves without meloxicam (0.55 kg/day; p=0.011), but an interaction between operator and meloxicam treatment (p=0.056) meant that meloxicam treatment did not increase growth rates in veterinary-disbudded calves (0.63 vs. 0.64 kg/day; p=0.872). From Days 16-30 there was no significant effect of meloxicam on growth rate, but veterinarian-disbudded calves grew faster (0.76 kg/day) than farmer-disbudded calves (0.66 kg/day; p=0.034). Overall, for the first 30 days after disbudding, if meloxicam was not used', veterinarian-disbudded calves grew faster than farmer-disbudded calves (p=0.002). However if meloxicam was used at disbudding there was no difference in growth rate between veterinarian- and farmer-disbudded calves (p=0.878). Mean cumulative milk consumption for the 11 days after disbudding was greater for calves disbudded by veterinary staff than by farm staff (p<0.001), but there was no effect of meloxicam treatment (p=0.618) and no interaction with operator (p=0.86) on cumulative milk consumption. CONCLUSIONS: Three to 6-week-old dairy calves disbudded by farm staff with no analgesia grew significantly slower over the next 15 days than farmer-disbudded calves given meloxicam, and slower over the next 30 days than veterinarian-disbudded calves given xylazine and lignocaine. However addition of meloxicam to the latter protocol had no effect on growth rate. Milk intake was significantly higher for 11 days for veterinarian- compared with farmer-disbudded calves. CLINICAL RELEVANCE: This study adds to the evidence that analgesia during disbudding is beneficial for calf productivity as well as calf welfare.

Diagnosis of the Cu and Se status of dairy cattle in New Zealand: how many samples are needed?

AIM: To determine the minimum number of samples required to obtain a robust estimate of the Cu and Se status of dairy herds, as assessed by determining liver Cu and serum Se concentrations. METHODS: Results were collated from analyses of samples of liver from 18 dairy herds and serum from 19 herds, for concentrations of Cu and Se, respectively. All herds were in either the Manawatu or Rangitikei regions of the North Island of New Zealand. Data were used to determine the required sample size for each herd; firstly to estimate the population mean with 90% confidence with a precision of 27.5 nmol/L for Se in serum, and 100 µmol/kg fresh weight (FW) for Cu in liver; and secondly to ensure that the 90% CI of the sample mean did not include specified thresholds for concentrations of Se or Cu. RESULTS: For Se concentration in serum, the SD of each batch varied from 0.5-147 nmol/L, and for Cu concentration in liver, the SD varied from 173-829 µmol/kg FW. For Se, the minimum sample size required to estimate the population mean to within 27.5 nmol/L with 90% confidence was >10 for 13/19 batches. For Cu, the minimum sample size required to estimate the population mean to within 100 µmol/kg FW was >10 for 17/18 batches. When estimating required sample size based on 90% CI and a threshold value, the minimum sample size to confirm the population mean of Se was >140 nmol/L was four in 17/18 batches where the sample mean was>140 nmol/L. For concentrations of Cu in liver, ≤8 samples would have been sufficient for a threshold of 45 µmol/kg FW in 16/18 batches. For the 95 µmol/kg threshold, the minimum required was 12. For the threshold of 300 µmol/kg FW, 6/17 batches with a mean >300 µmol/kg FW required ≤ 20 samples. CONCLUSIONS: From this dataset of 21 herds, the sample size recommendation for ensuring that the population mean of Se concentration was not below the marginal threshold was similar to previous recommendations. For Cu concentrations in liver, the estimated sample size recommendations for ensuring that the population mean was not below the marginal threshold was much larger than currently recommended. CLINICAL RELEVANCE: In dairy cattle, five to six blood samples per group should be taken to determine Se status, and to effectively monitor Cu status a minimum of 12 liver samples should be taken, preferably in the autumn.

Effect of use of teat sealants at drying off on the uptake of colostral antibodies by calves, as estimated by measuring gamma-glutamyl transferase activity.

AIM: To determine the effect of using internal teat sealants in cows at drying off on the immune status of their calves, as indicated by activity of gamma glutamyl transferase (GGT) in serum, within 24 h of birth. METHODS: Cows in one herd were treated at drying off with intramammary 600-mg cloxacillin and either no additional treatment or treatment with internal teat sealant containing bismuth subnitrate. Subsequently after calving, blood samples were collected from 35 calves after separation from their dams and prior to being fed pooled colostrum. Calves were collected once daily. Activity of GGT in serum was measured. The influence of treatment of the dam with teat sealant on activity of GGT in serum of the calf, and thus the transfer of colostral antibodies directly from the dam to the calf, was assessed. RESULTS: Activity of GGT in serum ranged from 8 to 8,560 IU/L. Of the 35 calves sampled only three (two from dams that were not treated with internal teat sealant) had GGT activity < 200 IU/L, indicative of the failure of passive transfer of antibodies. Median activity of GGT in calves from dams treated with teat sealant was 2,643 IU/L while that in calves from dams which were not treated with teat sealant was 2,286 IU/L. There was no effect of treatment with teat sealant or date of sampling on activity of GGT in serum (p > 0.1). CONCLUSIONS: Treatment of cows with internal teat sealant at drying off had no effect on transfer of colostral antibodies following calving. CLINICAL SIGNIFICANCE: The use of teat sealants is not likely to impact on colostrum uptake on farms where direct transfer of colostral antibodies between dam and calf is good. On farms where such direct transfer is poor, early supplementation of all calves with colostrum is likely to be required to prevent the failure of passive transfer, so any impact of teat sealants on uptake of colostrum is likely to be of little consequence.

Possible subclinical hepatopathy after copper supplementation in farmed red deer.

AIM: To determine the effect of parenteral supplementation with Cu on the activities of hepatic enzymes in deer with adequate concentration(s) of Cu in liver and serum. METHODS: Male red deer aged 12 months were given either 0.8 or 1.6 mg of Cu/kg of a S/C injectable Cu formulation or no Cu (n=10/group) on 03 December 2007 (Day 0). Concentration of Cu in liver was measured in biopsies taken on Days -13 and 17, and that in serum on Days 0, 1, 3 and 17. Liver enzymes, gamma-glutamyl transferase (GGT) and glutamate dehydrogenase (GDH), were measured in serum on Days 3 and 7. Deer were weighed on Days 0 and 17. RESULTS: The mean concentration of Cu in liver was 203 (range 50-460) µmol/kg fresh weight (FW) on Day -13 and that in serum was 14.8 (range 7.8-25.0) µmol/mL on Day 0. Concentrations of Cu in liver were adequate (>100 µmol/kg FW) in 25/30 deer. Injection with 0.8 mg of Cu/kg resulted in elevated mean concentrations of Cu in serum to 20.3 (range 14-26) and 17.4 (range 12-26) µmol/mL on Days 1 and 3 respectively, whereas 1.6 mg/kg resulted in mean concentrations of Cu in serum of 26.7 (range 20-42) and 19.3 (range 16-25) µmol/mL on Days 1 and 3 respectively (p<0.05). The mean concentration of Cu in liver on Day 17 was 1,460 (range 1,000-2,300) after injection with 0.8 mg/kg, 1,666 (range 1,100-2,200) after 1.6 mg/kg, and 280 (range 75-420) µmol/kg FW in controls. Injection with 1.6 mg Cu/kg, but not 0.8 mg/kg, resulted in an increase in the activity of GGT (p=0.05), and in 4/10 deer a marked change in the activity of GDH, between Day 3 and Day 7, indicating that injection of copper induced a moderate degree of subclinical hepatopathy. Mean liveweight gain (g/day) to Day 17 was 105.9 (range -176 to 411) in control animals and 64.7 (range -59 to 176) 64.7 and -61.7 (range -294 to 117) in deer given 0.8 and 1.6 mg/Cu/kg respectively (p=0.003). CONCLUSIONS: S/C administration of 1.6 mg of Cu/kg in deer which had adequate Cu status pre-treatment resulted in elevated activities of GGT and GDH in serum, indicating hepatopathy, and both this dose rate and 0.8 mg/kg resulted in reduced liveweight gain post-treatment compared with untreated controls. CLINICAL SIGNIFICANCE: Cu supplementation should not be administered when the Cu status of deer is adequate or unknown.

The effect of parenteral supplementation of vitamin E with selenium on the health and productivity of dairy cattle in the UK.

Recent work has suggested that the recommended intakes of vitamin E for dairy cattle need to be increased, particularly in dry cows. However, these suggestions are based on data from cattle in the USA, which may have significantly different oxidative stresses than European cattle. This study, which involved 594 cattle on three dairy farms, was designed to determine the effect of increased vitamin E supplementation on the health and fertility of UK dairy cows. Cattle were randomly allocated to receive either two intramuscular injections of 2100 mg of vitamin E (and 7 g of sodium selenite) 2 weeks before calving and on the day of calving, or no additional vitamin E supplementation. Although supplementation had no effect on milk yield, reproductive efficiency, or incidence of uterine infections, supplemented cattle had a lower risk of culling and a lower rate of mastitis. These figures were economically significant but not statistically significant at the 10% level. Supplementation reduced the incidence of retained fetal membranes from 6.5% to 3%, an effect which was almost significant at the 5% level. If these data are representative they suggest that vitamin E recommendations for UK cattle should be reassessed.

Failure of zinc supplementation to prevent severe facial eczema in cattle fed excess copper.

CASE HISTORY: A 400-cow dairy unit in the Waikato suffered a severe outbreak of facial eczema (FE) despite consistent zinc supplementation and significantly elevated serum zinc concentrations. CLINICAL FINDINGS: FE prevention had begun in mid-January 2006, via zinc sulphate supplementation in the water. Photosensitisation was reported on 06 April, contemporaneous with a marked increase in the number of Pithomyces chartarum spores in pasture samples. Within 10 days of this first clinical case, 100 affected cows had been dried off, eight of which subsequently died or were culled. Blood samples were collected from ten affected cows; all had serum zinc concentrations >17 micromol/L, and eight had gamma-glutamyl transferase (GGT) activities >200 U/ml, indicating that the photosensitisation was secondary to liver damage, i.e. probably FE. Further investigation identified that this herd had been receiving excess copper supplementation; 4/6 culled cows had liver copper concentrations within or above the marginal range for copper toxicity. DIAGNOSIS: Severe FE despite zinc supplementation that increased serum zinc concentrations above recommended levels. CLINICAL RELEVANCE: As zinc supplementation significantly reduces apparent copper status, copper supplementation is often used to counteract this. Previous excess copper intake may reduce the efficacy of zinc in preventing FE, thus copper intake should be assessed prior to the start of zinc supplementation.

The effect of housing and methionine intake on hoof horn hemorrhages in primiparous lactating Holstein cows.

This study investigated the effects of housing and nutrition on the development of hoof horn disease (as identified by the appearance of hoof horn hemorrhages) in primiparous lactating Holstein cows. The first objective was to investigate whether replacing butyl rubber mats in cubicles (free stalls) with thicker mattresses filled with chopped rubber would significantly reduce hoof horn hemorrhages, and if this reduction would so affect the level of hoof horn hemorrhages as to make it similar to that observed in primiparous cows in straw yards. The second objective was to investigate the effect of methionine supplementation for the first 13 wk of lactation on the development of such hemorrhages. This study confirmed that both sole and white line hemorrhages increase during early lactation in housed cows, although the pattern of development of white line hemorrhages is not identical to that of sole hemorrhages. Housing primiparous cows in straw yards after calving significantly reduced the development of hoof horn hemorrhages, but replacing cubicle mats with thicker mattresses had no significant effect. Providing 115% of calculated methionine requirements had no significant impact on the development of hoof horn hemorrhages.